Table of Contents
- What is the NIAID Policy for Extension of Investigator-Initiated Clinical Trials?
- Why did NIAID adopt this approach?
- Who can qualify for an administrative extension?
- When would I need an administrative extension?
- Are there circumstances when an administrative extension would not be appropriate?
- If I run out of money, can I still qualify?
- What can an administrative extension support?
- What if my research does not meet the NIH definition of a clinical trial?
- What if my ongoing clinical trial is a part of a training grant or fellowship?
- Can I apply if my clinical trial is part of a single project grant or one project on a multiproject grant?
- Are there benefits to PIs other than those listed above?
- Where can I find more information about clinical trial planning and implementation grants for new clinical trials?
- What's the first thing I should do if I think I’m eligible for an administrative extension?
- Can I still submit a renewal application for my investigator-initiated clinical trial grant?
- Does this approach affect requests for applications or solicitations?
- Does an administrative extension apply to clinical trials initiated under program announcements?
- Can anyone apply for an administrative extension?
- Do NIAID's clinical terms of award apply to my administrative extension?
Questions on Applying
- How do I apply for an administrative extension?
- What information may NIAID request to help determine whether I am a candidate?
- Do I need to prepare a letter of intent?
- How do I know if I am a candidate for an administrative extension?
- What is the timeframe for a response from NIAID regarding approval to submit my application?
- How much time can I request for an administrative extension?
- How much money can I request for an administrative extension?
- When can I submit my administrative extension package?
- Should I indicate on the face page of my administrative extension application that human subjects are involved?
- How do I prepare and submit my administrative extension application package?
- Where should I send my administrative extension application package if NIAID invites me to submit one?
- What notice should I indicate on the face page?
- Can I submit a revised administrative extension application package?
- Do I need permission to submit an administrative extension application?
- Should I submit an administrative extension package electronically?
NIAID Approval and Review Questions
- How does the NIAID process for evaluating administrative extension packages differ from peer review?
- Who will peer review the administrative extension applications?
- If I am not an NIAID grantee, how can I renew my clinical trial grant?
- What if my question wasn't answered here or if I'd like to suggest a question?
The NIAID Policy for Extension of Investigator-Initiated Clinical Trials provides PIs on investigator-initiated clinical trials with funds to complete or terminate a trial in an orderly fashion, under certain circumstances.
Occasionally, NIAID may administratively extend a clinical trial that could not be completed within the award period and budget. If the competing renewal process is more complex than is warranted, we may use a streamlined noncompetitive process, described in the NIAID Policy for Extension of Investigator-Initiated Clinical Trials.
You must be an NIAID grantee and meet the criteria in When would I need an administrative extension?
This approach is appropriate if a delay occurs for reasons you cannot anticipate or control, the reasons have been adequately addressed, and the clinical trial remains a high priority for NIAID.
You may be eligible for a noncompetitive extension if you have resolved delays associated with the following reasons:
- Difficulties obtaining suitable study agent.
- Difficulties meeting enrollment schedule.
- Difficulties obtaining assurances and certifications.
- Difficulties with access to suitable facilities.
- External hold ups at regulatory or funding agencies (not related to safety).
- Litigation involving any of the above.
- Changes in public health policy or standards of care.
Yes. Administrative extensions do not support extension of clinical trials due to the following types of delays:
- Natural disasters or declared emergencies (NIH will address these situations).
- Safety concerns.
- Persistent systemic problems.
- Suspension of grant activities.
- Vandalism or other isolated events unrelated to the trial.
No. You must have funds remaining to qualify for an administrative extension. If you run out of money, you can apply for an administrative supplement. Go to the Administrative Supplements to Grants and Cooperative Agreements SOP.
An administrative extension can support the full range of activities associated with clinical trials, including activities for the initial grant as well as those necessary to complete the trial during the extension period. In this way, it is the same as a traditional R01 or U01 clinical trial grant.
If your study does not meet the NIH Definition of Clinical Trial, it is not eligible for an administrative extension.
NIAID determines on a case-by-case basis if the clinical trial is being conducted under a training or fellowship grant. If appropriate, NIAID would consider providing funds to complete the clinical trial portion of the parent grant separately.
Can I apply if my clinical trial is part of a single project grant or one project on a multiproject grant?
If the clinical trial is part of a larger study, NIAID determines this on a case-by-case basis. NIAID may consider extending the clinical trial portion of the parent grant separately.
Yes. Application packages for administrative extensions are short and undergo internal programmatic evaluation by NIAID staff instead of peer reviewers, so you can submit packages to NIAID at any time. The time between submission of the application package and a funding decision can be as little as 90 days.
Where can I find more information about clinical trial planning and implementation grants for new clinical trials?
Go to our Investigator-Initiated Clinical Trial Resources page.
Go to the Investigator-Initiated Clinical Trial Administrative Extension SOP and follow the instructions.
If you conclude that you are a potential candidate, prepare all the required information listed in the NIAID Policy for Extension of Investigator-Initiated Clinical Trials Guide notice and contact the appropriate NIAID program official listed in the Investigator-Initiated Clinical Trial Administrative Extension SOP.
Yes. However, it will undergo the standard review process at NIH's Center for Scientific Review.
No. The NIAID Policy for Extension of Investigator-Initiated Clinical Trials is only for investigator-initiated applications. NIAID may make some exceptions if the solicitation (RFA/ PAR) is not reissued and the trial meets the criteria for this policy.
Yes. Because grant applications submitted in response to program announcements are considered investigator-initiated, clinical trials sponsored under program announcements and notices are eligible, especially if the program announcement or notice is terminated.
No. You must be a PI on an investigator-initiated clinical trial grant, and NIAID must invite you to apply. NIAID program staff will determine if you are a candidate. For more information, see the Investigator-Initiated Clinical Trial Administrative Extension SOP.
Yes. NIAID Clinical Terms of Award will be part of the terms and conditions of award. Please see the NIAID Clinical Trial Implementation Cooperative Agreement (U01, Clinical Trial Required) program announcement for sample terms and conditions of award, which will be modified for each cooperative agreement.
Follow these steps:
- Review the Investigator-Initiated Clinical Trial Administrative Extension SOP for the information to discuss with the appropriate NIAID Program Division Contact.
- Call or email the appropriate NIAID Program Division Contact to discuss your potential candidacy.
- Follow the instructions in the Guide notice and wait for NIAID to notify you. If you are a candidate for an extension award, you will receive an invitation to submit the application.
- See the questions below for further details.
If you are considering a request for permission to submit an administrative extension, please think about the following items at least 18 months before your award ends:
- Status of your clinical trial.
- Reason for the delay.
- Assurance that all problems have been addressed.
- Estimated time and funds needed to complete the study.
Then contact the appropriate NIAID Program Division Contact, who will determine what you need to send in based on the circumstances of your extension.
The NIAID division director will send you a letter officially inviting you to submit an administrative extension package. Include this letter in your package.
NIAID’s goal is to respond to you within eight weeks after you contact the appropriate NIAID Program Division Contact.
You can receive up to three years of support.
You may request funds up to the amount in the original grant with increases of up to 3 percent a year to perform the same work. However, under special circumstances and with adequate justification, we may provide funding for additional costs to perform the same work.
You may submit administrative extension packages to NIAID at any time. For earliest possible consideration for funding, submit it at least 90 days before a meeting of the NIAID Advisory Council.
Should I indicate on the face page of my administrative extension application that human subjects are involved?
Yes. Check the human subjects box on the face page.
Use an abbreviated form of the PHS 398 application kit to provide the information listed in the Guide notice, including a copy of the invitation from NIAID. Do not send your package to CSR, and do not apply electronically.
Where should I send my administrative extension application package if NIAID invites me to submit one?
Send your package to the Grants Management Program, NIAID. For details, read the NIAID Policy for Extension of Investigator-Initiated Clinical Trials Guide notice.
NOT-AI-07-012: NIAID Policy for Extension of Investigator-Initiated Clinical Trials.
No. Except under exceptional circumstances, we will not extend a clinical trial more than once.
Yes. Only investigators who receive an official invitation letter from NIAID are allowed to submit administrative extension application packages.
No. Submit an abbreviated PHS 398 paper application.
How does the NIAID process for evaluating administrative extension packages differ from peer review?
NIAID staff, and possibly ad hoc consultants, will conduct an internal programmatic evaluation to determine whether you have adequately addressed the problems, your proposed research meets our current scientific priorities, and we can support the trial with existing resources. The review will use the criteria listed in the NIAID Policy for Extension of Investigator-Initiated Clinical Trials Guide notice.
Administrative extension applications do not undergo peer review.
We encourage you to contact other institutes to see if they might accept your renewal application because NIAID does not plan to routinely fund clinical trial grant renewals.
Use the contacts listed above for questions about your specific situation. If you have a general question or a suggestion to improve this page, email the Office of Knowledge and Educational Resources at firstname.lastname@example.org.